Singapore markets closed

Biodesix, Inc. (BDSX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.26000.0000 (0.00%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 144.50M
Enterprise value 178.91M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.11
Price/book (mrq)31.55
Enterprise value/revenue 3.64
Enterprise value/EBITDA -4.82

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 3-27.17%
S&P500 52-week change 321.08%
52-week high 32.2100
52-week low 31.0300
50-day moving average 31.4199
200-day moving average 31.5432

Share statistics

Avg vol (3-month) 3139.34k
Avg vol (10-day) 333.95k
Shares outstanding 5114.69M
Implied shares outstanding 6114.69M
Float 839.08M
% held by insiders 159.53%
% held by institutions 111.23%
Shares short (15 Apr 2024) 4315.04k
Short ratio (15 Apr 2024) 41.26
Short % of float (15 Apr 2024) 40.48%
Short % of shares outstanding (15 Apr 2024) 40.27%
Shares short (prior month 15 Mar 2024) 4181.14k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -106.23%
Operating margin (ttm)-46.67%

Management effectiveness

Return on assets (ttm)-26.89%
Return on equity (ttm)-414.09%

Income statement

Revenue (ttm)49.09M
Revenue per share (ttm)0.60
Quarterly revenue growth (yoy)52.70%
Gross profit (ttm)N/A
EBITDA -37.97M
Net income avi to common (ttm)-52.15M
Diluted EPS (ttm)-0.6400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.28M
Total cash per share (mrq)0.27
Total debt (mrq)61.46M
Total debt/equity (mrq)1,341.92%
Current ratio (mrq)1.19
Book value per share (mrq)0.05

Cash flow statement

Operating cash flow (ttm)-22.87M
Levered free cash flow (ttm)-35.6M